Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $287.15 | 3 | 74.2% |
| Education | $99.99 | 1 | 25.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Galderma Laboratories, L.P. | $263.13 | 2 | $0 (2018) |
| Janssen Biotech, Inc. | $99.99 | 1 | $0 (2021) |
| REVANCE THERAPEUTICS, INC. | $24.02 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $24.02 | 1 | REVANCE THERAPEUTICS, INC. ($24.02) |
| 2021 | $99.99 | 1 | Janssen Biotech, Inc. ($99.99) |
| 2018 | $147.27 | 1 | Galderma Laboratories, L.P. ($147.27) |
| 2017 | $115.86 | 1 | Galderma Laboratories, L.P. ($115.86) |
All Payment Transactions
4 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/04/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $24.02 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 04/22/2021 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $99.99 | General |
| Category: Immunology | ||||||
| 02/16/2018 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $147.27 | General |
| 06/20/2017 | Galderma Laboratories, L.P. | EPIDUO FORTE (Drug) | Food and Beverage | In-kind items and services | $115.86 | General |
| Category: ACNE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 2,373 | 11,297 | $587,775 | $218,556 |
| 2022 | 12 | 2,499 | 11,167 | $594,687 | $228,751 |
| 2021 | 17 | 2,860 | 12,849 | $688,085 | $274,717 |
| 2020 | 17 | 2,568 | 9,485 | $515,055 | $184,287 |
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 294 | 587 | $140,220 | $64,972 | 46.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 649 | 1,344 | $134,400 | $43,891 | 32.7% |
| 11901 | Injection into skin growth, more than 7 growths | Office | 2023 | 273 | 771 | $71,870 | $35,634 | 49.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 630 | 7,978 | $159,520 | $34,928 | 21.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 174 | 242 | $23,510 | $13,996 | 59.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 113 | 128 | $19,275 | $8,770 | 45.5% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 168 | 168 | $18,480 | $6,898 | 37.3% |
| 17263 | Destruction of cancer skin growth of trunk, arms, or legs, 2.1-3.0 cm | Office | 2023 | 24 | 29 | $8,325 | $3,586 | 43.1% |
| 17282 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 19 | 20 | $6,570 | $2,995 | 45.6% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 17 | 18 | $2,910 | $1,467 | 50.4% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 12 | 12 | $2,695 | $1,421 | 52.7% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 273 | 515 | $121,025 | $59,606 | 49.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 707 | 1,589 | $158,900 | $54,279 | 34.2% |
| 11901 | Injection into skin growth, more than 7 growths | Office | 2022 | 270 | 816 | $73,440 | $38,528 | 52.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 674 | 7,555 | $150,852 | $34,597 | 22.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 178 | 263 | $24,985 | $14,310 | 57.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 150 | 172 | $25,800 | $10,956 | 42.5% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 160 | 160 | $17,600 | $6,388 | 36.3% |
| 10060 | Simple or single drainage of skin abscess | Office | 2022 | 24 | 32 | $4,850 | $2,535 | 52.3% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2022 | 21 | 21 | $4,620 | $2,384 | 51.6% |
| 17282 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2022 | 18 | 19 | $6,270 | $1,928 | 30.7% |
| 17263 | Destruction of cancer skin growth of trunk, arms, or legs, 2.1-3.0 cm | Office | 2022 | 12 | 13 | $3,705 | $1,769 | 47.7% |
| 17281 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2022 | 12 | 12 | $2,640 | $1,472 | 55.7% |
| 17000 | Destruction of skin growth | Office | 2021 | 797 | 2,093 | $209,300 | $72,644 | 34.7% |
| 11901 | Injection of more than 7 skin growths | Office | 2021 | 272 | 992 | $89,280 | $47,267 | 52.9% |
About Dr. Gregory Piro, D.O
Dr. Gregory Piro, D.O is a Procedural Dermatology healthcare provider based in Howell, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/03/2007. The National Provider Identifier (NPI) number assigned to this provider is 1912054115.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gregory Piro, D.O has received a total of $387.14 in payments from pharmaceutical and medical device companies, with $24.02 received in 2024. These payments were reported across 4 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($287.15).
As a Medicare-enrolled provider, Piro has provided services to 10,300 Medicare beneficiaries, totaling 44,798 services with total Medicare billing of $906,312. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Practice Information
- Specialty Procedural Dermatology
- Other Specialties Specialist, Dermatology
- Location Howell, MI
- Active Since 01/03/2007
- Last Updated 06/16/2021
- Taxonomy Code 207NS0135X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1912054115
Products in Payments
- EPIDUO FORTE (Drug) $115.86
- TREMFYA (Drug) $99.99
- DAXXIFY (Drug) $24.02
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.